Entrada Therapeutics | Financial Information

SEC Filings

SEC Filings
Filing date	Form	Description	Filing Group	View
Apr 25, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Proxy Filings	View HTML 0001104659-23-049258.pdf 0001104659-23-049258.rtf 0001104659-23-049258.xls
Apr 25, 2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0001104659-23-049260.pdf 0001104659-23-049260.rtf
Apr 25, 2023	ARS	An annual report to security holders	Annual Filings	View HTML 0001104659-23-049262.pdf 0001104659-23-049262.rtf
Apr 19, 2023	4/A	Amendment to a previously filed 4	3,4,5	View HTML 0001689375-23-000026.pdf 0001689375-23-000026.rtf 0001689375-23-000026.xls
Apr 19, 2023	4/A	Amendment to a previously filed 4	3,4,5	View HTML 0001689375-23-000027.pdf 0001689375-23-000027.rtf 0001689375-23-000027.xls